Company logo

RIGL - Rigel Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
South San Francisco, United States
Type: Equity

RIGL price evolution
RIGL
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $32.79 $45.41 $48.81 $40.28
Short term investments $24.15 $16.94 $15.54 $18.38
Net receivables $30.55 $23.55 $20.82 $29.37
Inventory $5.52 $6.11 $10.78 $11.08
Total current assets $99.27 $95.02 $100.92 $106.97
Long term investments
Property, plant & equipment $1.03 $1.2 $1.21 $1.42
Goodwill & intangible assets $13.88 $14.15 $14.41 $14.68
Total noncurrent assets $17.96 $20.3 $16.17 $16.64
Total investments $24.15 $16.94 $15.54 $18.38
Total assets $117.22 $115.32 $117.09 $123.61
Current liabilities
Accounts payable $7.14 $8 $5.24 $6.29
Deferred revenue $17.04 $15.9 $15.04 $15.46
Short long term debt $7.92 $0.67 $0.47 $0.45
Total current liabilities $53.27 $48.27 $44.02 $45.52
Long term debt $52.66 $60.13 $60.2 $60.29
Total noncurrent liabilities $92.6 $98.89 $101.18 $102.35
Total debt $60.58 $60.8 $60.67 $60.73
Total liabilities $145.87 $147.16 $145.21 $147.87
Shareholders' equity
Retained earnings -$1407.55 -$1408.29 -$1402.6 -$1395.99
Other shareholder equity $0.01 -$0.01 -$0.03 -$0.03
Total shareholder equity -$28.64 -$31.83 -$28.11 -$24.26
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $32.79 $24.46 $18.89 $30.37
Short term investments $24.15 $33.75 $106.08 $26.95
Net receivables $30.55 $40.32 $15.47 $15.97
Inventory $5.52 $9.12 $6.62 $1.64
Total current assets $99.27 $115.9 $154.47 $88.98
Long term investments
Property, plant & equipment $1.03 $2.79 $11.89 $20.57
Goodwill & intangible assets $13.88 $14.95
Total noncurrent assets $17.96 $18.38 $12.86 $21.39
Total investments $24.15 $33.75 $106.08 $26.95
Total assets $117.22 $134.28 $167.33 $110.38
Current liabilities
Accounts payable $7.14 $22.51 $3.79 $3.71
Deferred revenue $17.04 $13.51 $2.6 $3.02
Short long term debt $7.92 $1.13 $9.89 $8.62
Total current liabilities $53.27 $65.21 $63.55 $40.84
Long term debt $52.66 $39.45 $20.67 $30.47
Total noncurrent liabilities $92.6 $82.68 $73.4 $35.51
Total debt $60.58 $41.55 $30.57 $39.09
Total liabilities $145.87 $147.9 $136.95 $76.35
Shareholders' equity
Retained earnings -$1407.55 -$1382.46 -$1323.89 -$1305.97
Other shareholder equity $0.01 -$0.15 -$0.1 -$0
Total shareholder equity -$28.64 -$13.62 $30.37 $34.03
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $35.79 $28.13 $26.89 $26.07
Cost of revenue $3.79 $1.27 $1.07 $0.98
Gross Profit $32 $26.87 $25.81 $25.09
Operating activities
Research & development $3.19 $6.47 $4.77 $10.09
Selling, general & administrative $26.85 $24.86 $26.31 $27.73
Total operating expenses $30.04 $31.33 $31.08 $37.82
Operating income $1.97 -$4.46 -$5.27 -$12.72
Income from continuing operations
EBIT $2.64 -$3.79 -$4.74 -$12.33
Income tax expense
Interest expense $1.91 $1.9 $1.86 $1.2
Net income
Net income $0.74 -$5.69 -$6.6 -$13.54
Income (for common shares) $0.74 -$5.69 -$6.6 -$13.54
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $116.88 $120.24 $149.24 $108.62
Cost of revenue $7.11 $1.75 $1.08 $0.9
Gross Profit $109.77 $118.49 $148.15 $107.73
Operating activities
Research & development $24.52 $60.27 $65.24 $60.1
Selling, general & administrative $105.74 $112.45 $91.89 $76.6
Total operating expenses $130.26 $174.04 $160.65 $136.7
Operating income -$20.49 -$55.55 -$12.5 -$28.97
Income from continuing operations
EBIT -$18.22 -$54.87 -$12.45 -$28.39
Income tax expense $0.6
Interest expense $6.87 $3.71 $4.86 $1.35
Net income
Net income -$25.09 -$58.57 -$17.91 -$29.74
Income (for common shares) -$25.09 -$58.57 -$17.91 -$29.74
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $0.74 -$5.69 -$6.6 -$13.54
Operating activities
Depreciation $0.29 $0.29 $0.3 $0.36
Business acquisitions & disposals
Stock-based compensation $1.93 $1.94 $2.17 $2.76
Total cash flows from operations -$6.24 -$1.36 $5.93 -$4.07
Investing activities
Capital expenditures $0.11 $0.02 $0.13
Investments -$6.98 -$1.19 $2.97 $15.65
Total cash flows from investing -$6.87 -$1.17 $2.97 $0.78
Financing activities
Dividends paid
Sale and purchase of stock $0.49 $0.01 $0.55 $0
Net borrowings $19.95
Total cash flows from financing $0.49 -$0.87 -$0.37 $19.12
Effect of exchange rate
Change in cash and equivalents -$12.63 -$3.4 $8.53 $15.83
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$25.09 -$58.57 -$17.91 -$29.74
Operating activities
Depreciation $1.24 $1 $1.16 $0.71
Business acquisitions & disposals
Stock-based compensation $8.81 $12.38 $9.49 $7.3
Total cash flows from operations -$5.74 -$73.76 $5.88 -$52.19
Investing activities
Capital expenditures $0.26 $0.44 -$0.63 -$1.26
Investments $10.44 $72.33 -$79.41 $48.73
Total cash flows from investing -$4.3 $72.78 -$80.04 $47.47
Financing activities
Dividends paid
Sale and purchase of stock $1.05 $2.12 $4.78 $2.6
Net borrowings $19.95 $19.54 $9.97
Total cash flows from financing $18.37 $6.55 $62.67 $12.57
Effect of exchange rate
Change in cash and equivalents $8.33 $5.57 -$11.48 $7.85
Fundamentals
Market cap $258.74M
Enterprise value $286.53M
Shares outstanding 174.83M
Revenue $116.88M
EBITDA -$16.98M
EBIT -$18.22M
Net Income -$25.09M
Revenue Q/Q -30.20%
Revenue Y/Y -2.79%
P/E ratio -10.31
EV/Sales 2.45
EV/EBITDA -16.87
EV/EBIT -15.73
P/S ratio 2.21
P/B ratio -9.03
Book/Share -0.16
Cash/Share 0.19
EPS -$0.14
ROA -21.21%
ROE 88.94%
Debt/Equity -5.09
Net debt/EBITDA -6.66
Current ratio 1.86
Quick ratio 1.76